| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IMLET.2017.09.007 |
| P698 | PubMed publication ID | 28919455 |
| P2093 | author name string | Carlo Chizzolini | |
| Nicolò Costantino Brembilla | |||
| Aleksandra Maria Dufour | |||
| P2860 | cites work | Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor | Q28273769 |
| Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells | Q37061893 | ||
| Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells | Q43991749 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-09-14 | |
| P1433 | published in | immunology Letters | Q15766068 |
| P1476 | title | Is there a role for IL-17 in the pathogenesis of systemic sclerosis? |
| Q60935583 | Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis |
| Q61445191 | Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches |
| Q90454739 | IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis |
| Q58785737 | Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1 |
| Q90727910 | Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis |
| Q64077435 | Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis |
| Q90345176 | T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis |
| Q64111557 | TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity |
| Q97420826 | The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis |
Search more.